PHOENIX Releases Video Promoting Single Entry Point
As a Single Entry Point, PHOENIX SEP offers a top-tier and consolidated network of facilities, technologies, services and expertise to bridge and facilitate the path of nanopharmaceuticals from bench to bedside. We cover all the R&D/I and technology transfer aspects from characterization, testing, verification up to scale-up, GMP manufacturing and regulatory guidance in a timely and cost-friendly manner.
PHOENIX supports its customers to overcome the “innovation valley of death”, enabling transfer of nanopharmaceuticals from lab bench to clinical trials.
To reach potential customers, we have created a video with footage from our 2nd satellite event at NanoMed Europe in Barcelona and interviews from Nazende Günday-Türeli, Matthias Jourdain and Eleonora Rizzi (MyBiotech / PHOENIX SEP) and Tommaso Serchi (LIST, coordinator of PHOENIX-OITB).
Click the button below to watch on our YouTube channel!
